InVivo Therapeutics announces enrolment of third patient in pilot spinal cord injury trial


A third patient has been enrolled in InVivo Therapeutics’ ongoing pilot trial of its investigational Neuro-Spinal Scaffold in patients with acute spinal cord injury at the Carolinas Medical Center, part of the Carolinas HealthCare System in Charlotte, USA.

Dom Coric, of the Carolina Neurosurgery and Spine Associates and Chief of Neurosurgery at Carolinas Medical Center, together with William Bockenek, chief medical officer at Carolinas Rehabilitation, are co-principal Investigators at this site. Coric, along with Mark Smith of the Carolina Neurosurgery and Spine Associates, performed the third-ever Neuro-Spinal Scaffold implantation into an acute spinal cord injury patient. The implantation took place about three and a half days after the injury. Coric said, “The implantation procedure went smoothly and the patient is doing very well. It has been rewarding to be involved in this clinical study, and I look forward to following the patient’s progress.”

Mark Perrin, InVivo’s chief executive officer and chairman, said, “This third patient affords us the opportunity to further extend our experience with the Neuro-Spinal Scaffold and will provide us with additional data for the design of a future pivotal study.”